Strategy Asset Managers’s Amedisys AMED Stock Holding History

Strategy Asset Managers’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,298	Closed	-$344K	–	268
2021 Q1	$344K	Buy	+1,298	New	+$366K	0.08%	174
2020 Q1	–	Sell	-1,828	Closed	-$305K	–	182
2019 Q4	$305K	Buy	+1,828	New	+$272K	0.08%	168

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Strategy Asset Managers's AMED Position: Q2 2021 in Review

Strategy Asset Managers sold out of Amedisys (AMED) in Q2 2021, closing a stake of 1,298 shares — an estimated $344K sold.

Strategy Asset Managers first reported a position in AMED in Q4 2019 and held it in 2 quarters. The position peaked at $344K in Q1 2021. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

Strategy Asset Managers reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
Strategy Asset Managers sold 1,298 Amedisys shares in Q2 2021, an estimated $344K.
Strategy Asset Managers first reported a position in Amedisys in Q4 2019 and held it in 2 quarters.
Strategy Asset Managers's Amedisys position peaked at $344K in Q1 2021.
375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Strategy Asset Managers's 13F filing for Q2 2021, filed 4 Aug 2021.